| Category | Microbiome Skincare |
| Founded | 2018 |
| Headquarters | Jinan |
| Listing | Not separately listed; part of Freda (600223.SH) |
| Latest revenue | FY2025 brand revenue RMB 947m, down 27.17% |
| Hero SKUs | Probiotic Toner & Lotion / 287 Mask |
Brand History
Launched in 2018 by Freda Bio, Dr.Alva was among the first domestic brands to propose 'microbiome skincare'. Leveraging Freda's hyaluronic acid and fermentation capabilities, it focused on skin flora balance, combining probiotics, prebiotics and postbiotics in a then-novel 'barrier plus flora' story.
The probiotic toner-lotion and 287 mask are signatures — the former for daily maintenance, the latter building word of mouth on barrier repair. Distribution is mainly online with single-brand stores, once exceeding 500 outlets. Revenue fell 27.17% to RMB 947m in 2025 on channel and portfolio adjustments, with the company reporting sequential recovery from Q3; Freda's cosmetics segment totalled RMB 2.25bn.
Hero Products
Three-Year Financials
| Year | Revenue (RMB bn) | YoY | Net profit (RMB bn) |
|---|---|---|---|
| 2024 | 13.00 | — | — |
| 2025 | 9.47 | -27.17% | — |
Brand-level：Dr.Alva posted RMB 947m in 2025, down 27.17%, overtaken by sister brand Rellet (RMB 1.04bn); Freda's cosmetics segment totalled RMB 2.25bn.
Source：Freda FY2025 annual report (600223.SH); company newsroom
Company Coverage
- 2026-04Freda FY2025: Dr.Alva at RMB 947m, -27.17%
Channel and portfolio adjustments drove the decline; the company reports sequential recovery from Q3.
Source：Annual report - 2025-09Single-brand stores exceed 500
Offline runs through single-brand stores and clinics.
Source：Company newsroom - 2025-03Royal jelly acid line launched
A bio-synthesised ingredient used to sharpen the tech positioning.
Source：Company newsroom
Observation: Dr.Alva's 27.17% decline in 2025 reflects both cooling microbiome narratives and channel adjustment. The lesson: once concepts like flora balance are widely adopted, first-mover advantage evaporates. Single-brand stores are its differentiated asset, but with high costs it must balance pricing discipline against experience, or repeat the old pattern of online growth and offline losses.